Browse by Research Project Code

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0

Ciani, O. et al. (2023) A framework for the definition and interpretation of the use of surrogate endpoints in interventional trials. EClinicalMedicine, 65, 102283. (doi: 10.1016/j.eclinm.2023.102283) (PMID:37877001) (PMCID:PMC10590868)

Manyara, A. M. et al. (2023) Definitions, acceptability, limitations, and guidance in the use and reporting of surrogate endpoints in trials: a scoping review. Journal of Clinical Epidemiology, 160, pp. 83-99. (doi: 10.1016/j.jclinepi.2023.06.013) (PMID:37380118)

Ciani, O., Manyara, A. M. , Chen, A.-W. and Taylor, R. S. (2022) Surrogate endpoints in trials: a call for better reporting. Trials, 23, 991. (doi: 10.1186/s13063-022-06904-7) (PMID:36503559) (PMCID:PMC9743760)

Manyara, A. M. et al. (2022) Protocol for the development of SPIRIT and CONSORT extensions for randomised controlled trials with surrogate primary endpoints: SPIRIT-SURROGATE and CONSORT-SURROGATE. BMJ Open, 12(10), e064304. (doi: 10.1136/bmjopen-2022-064304) (PMID:36220321) (PMCID:PMC9557267)

Manyara, A. , Davies, P., Stewart, D., Wells, V. , Weir, C., Young, A., Taylor, R. and Ciani, O. (2022) Scoping and targeted reviews to support development of SPIRIT and CONSORT extensions for randomised controlled trials with surrogate primary endpoints: protocol. BMJ Open, 12(10), e062798. (doi: 10.1136/bmjopen-2022-062798) (PMID:36229145) (PMCID:PMC9562307)

Ciani, O., Manyara, A. M. and Taylor, R. S. (2022) Need for better reporting of trials with surrogate endpoints – SPIRIT|CONSORT-SURROGATE extensions. Journal of Epidemiology and Community Health, 76(9), pp. 769-770. (doi: 10.1136/jech-2022-219294) (PMID:35750481) (PMCID:PMC9380472)

Ciani, O., Manyara, A. M. and Taylor, R. S. (2022) Surrogate endpoints in trials – a call for better reporting. British Medical Journal, 378, o1912. (doi: 10.1136/bmj.o1912) (PMID:35905986)

Manyara, A. M. , Ciani, O. and Taylor, R. S. (2022) A call for better reporting of trials using surrogate primary endpoints. Alzheimer's and Dementia: Translational Research and Clinical Interventions, 8(1), e12340. (doi: 10.1002/trc2.12340) (PMID:35910671) (PMCID:PMC9323346)

Weir, C. J. and Taylor, R. S. (2022) Informed decision‐making: statistical methodology for surrogacy evaluation and its role in licensing and reimbursement assessments. Pharmaceutical Statistics, 21(4), pp. 740-756. (doi: 10.1002/pst.2219) (PMID:35819121) (PMCID:PMC9546435)

Manyara, A. M. , Ciani, O. and Taylor, R. S. (2022) Reply to Commentary by Cummings (2022): Surrogate endpoints extend beyond biomarkers. Alzheimer's and Dementia, 8(1), e12344. (doi: 10.1002/trc2.12344) (PMID:35910664) (PMCID:PMC9323349)

This list was generated on Thu Apr 18 05:46:53 2024 BST.